Targeting myeloid-derived suppressor cells and the PD-1/PD-L1 axis to enhance immunotherapy with anti-CEA designer T cells for the treatment of colorectal liver metastases.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Roger Williams Medical Center, Boston University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2528927922
